SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review. - Seidu, Samuel; Alabraba, Vicki; Davies, Sarah; Newland-Jones, Philip; Fernando, Kevin; Bain, Stephen C.; Diggle, Jane; Evans, Marc; James, June; Kanumilli, Naresh; Milne, Nicola; Viljoen, Adie; et al. (Diabetes Therapy, 2024)